NCT00862589View on ClinicalTrials.gov

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
HyperglycemiaHyperglucagonemiaGlucose Intolerance
Interventions
OTHER

GLP-1 infusion

physiological effect of GLP-1

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT00862589 - Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter